Search results

Page title matches

• GLP-1
  == GLP-1 == '''GLP-1''' ('''G'''lucagon-'''L'''ike '''P'''eptide-1, /ˌɡluːkəˈɡɒn laɪk
  2 KB (242 words) - 04:14, 4 February 2024

Page text matches

• GLP-1
  == GLP-1 == '''GLP-1''' ('''G'''lucagon-'''L'''ike '''P'''eptide-1, /ˌɡluːkəˈɡɒn laɪk
  2 KB (242 words) - 04:14, 4 February 2024
• Tirzepatide
  ...d for the treatment of [[type 2 diabetes]] and [[obesity]]. It is a dual [[GLP-1]] and [[GIP]] receptor agonist that is designed to control blood glucose ...e a three-point attachment, referring to the drug's dual agonist action on GLP-1 and GIP receptors. "Zepatide" is a suffix used in pharmaceutical nomencla
  2 KB (222 words) - 23:53, 6 February 2024
• DPP4 inhibitors
  ...blood sugar levels. By inhibiting DPP4, these drugs increase the levels of GLP-1, thereby helping to control blood glucose levels. * [[GLP-1]]: A hormone that helps regulate blood sugar levels.
  2 KB (226 words) - 17:12, 9 February 2024
• Proglucagon
  ...peptides include glucagon-like peptide-1 (GLP-1), glucagon-like peptide-2 (GLP-2), and the major proglucagon fragment (MPGF). * [[Glucagon-like peptide-1 (GLP-1)]]: A peptide hormone of the glucagon family, secreted by the gut, that s
  2 KB (241 words) - 17:35, 6 February 2024
• Semaglutide
  ...s]] and [[obesity]]. It is a [[glucagon-like peptide-1 receptor agonist]] (GLP-1 RA) that is administered via injection. ...a meal and helps to regulate blood sugar levels. Semaglutide binds to the GLP-1 receptors in the pancreas, stimulating the release of insulin, which lowe
  1 KB (202 words) - 00:21, 7 February 2024
• Glucagon-like peptide-1
  '''Glucagon-like peptide-1''' ('''GLP-1''') is a [[peptide]] hormone that plays a crucial role in regulating [[bl GLP-1 is secreted by the [[L cells]] of the small intestine and colon in respon
  2 KB (221 words) - 15:08, 11 February 2024
• Liraglutide
  ...esity]]. It is a long-acting [[glucagon-like peptide-1 receptor agonist]] (GLP-1 receptor agonist), also known as incretin mimetics. ...c acid spacer on the remaining lysine residue at the N-terminal end of the GLP-1 molecule. This modification allows the molecule to bind to albumin within
  2 KB (207 words) - 17:52, 6 February 2024
• Incretin
  There are two main types of incretins: [[Glucagon-like peptide-1]] (GLP-1) and [[Glucose-dependent insulinotropic polypeptide]] (GIP). Both hormone ...avenous glucose administration. This effect is largely due to the hormones GLP-1 and GIP.
  2 KB (237 words) - 06:05, 5 February 2024
• Incretins
  There are two primary types of incretins: [[Glucagon-like peptide-1]] (GLP-1) and [[Glucose-dependent insulinotropic polypeptide]] (GIP). Both are sec GLP-1 is a hormone that is secreted from the [[L cells]] of the small intestine
  2 KB (233 words) - 20:14, 5 February 2024
• Teduglutide
  ...tide''' (pronounced as te-doo-gloo-tide) is a [[glucagon-like peptide-2]] (GLP-2) analog used for the treatment of [[short bowel syndrome]] (SBS). ...-amino acid [[polypeptide]] that is identical to naturally occurring human GLP-2, except for a single amino acid substitution.
  1 KB (184 words) - 23:55, 6 February 2024
• Wegovy
  ...) is a brand name for the drug [[semaglutide]], a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of [[obesity]]. ...cking the effects of a hormone in the body called glucagon-like peptide-1 (GLP-1). This hormone helps to regulate blood sugar levels and slows down the em
  1 KB (189 words) - 21:04, 4 February 2024
• Teneligliptin
  ...4). This enzyme is involved in the inactivation of the incretin hormones [[GLP-1]] and [[GIP]]. By inhibiting DPP-4, Teneligliptin increases the levels of * [[GLP-1]]: A hormone that is released in the intestines during a meal. It helps t
  2 KB (205 words) - 04:52, 7 February 2024
• Novo Nordisk
  ...sk's product portfolio includes a range of medicines, including insulin, [[GLP-1]] analogues for diabetes, haemophilia treatments, growth hormone therapie * [[GLP-1]]
  2 KB (224 words) - 22:58, 12 February 2024
• Insulin degludec/liraglutide
  ...]], a long-acting insulin, and [[liraglutide]], a glucagon-like peptide-1 (GLP-1) receptor agonist. * [[Glucagon-like peptide-1 (GLP-1) receptor agonist]]
  2 KB (227 words) - 19:22, 11 February 2024
• Exenatide
  ...[[Type 2 diabetes]]. It is a [[glucagon-like peptide-1 receptor agonist]] (GLP-1 receptor agonist) also referred to as incretin mimetics.
  1 KB (169 words) - 16:59, 5 February 2024
• Insulin glargine/lixisenatide
  ...th a long-acting insulin (insulin glargine) and a glucagon-like peptide-1 (GLP-1) receptor agonist (lixisenatide).
  2 KB (196 words) - 20:06, 7 February 2024
• Lixisenatide
  ...x-i-sen-a-tide) is a type of [[glucagon-like peptide-1 receptor agonist]] (GLP-1 receptor agonist) used in the treatment of [[Type 2 diabetes]]. It is mar
  1 KB (190 words) - 02:50, 7 February 2024
• Albiglutide
  ...pronounced al-bi-gloo-tide) is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) medication used for the treatment of [[Type 2 diabetes]
  2 KB (207 words) - 14:33, 6 February 2024
• Victoza
  ...) is a brand name for the drug [[liraglutide]], a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of [[type 2 diabetes]] and [[obes
  2 KB (220 words) - 04:19, 5 February 2024
• Dulaglutide
  ...sease]]. It is a long-acting [[glucagon-like peptide-1 receptor agonist]] (GLP-1 RA) that helps to control blood sugar levels and reduce cardiovascular ri
  2 KB (242 words) - 14:54, 6 February 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)